Background Chronic lung diseases and drugs used to treat patients with chronic lung
diseases may be associated with an increased fracture risk. Methods The design was a case …

Vestergaard P, Olsen ML, Paaske Johnsen S, Rejnmark L, Toft Sørensen H, Mosekilde L
(Aarhus University Hospital, Denmark; and Aarhus and Aalborg University Hospitals; …

Background. Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an
increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of …

Patients with chronic obstructive pulmonary disease (COPD) demonstrate a greater
osteoporosis prevalence than the general population. This osteoporosis risk may be …

The worldwide prevalence of chronic obstructive pulmonary disease (COPD) is growing
faster in women than in men. Over the past two decades, COPD‐related mortality rates have …

Harvey Cushing first described the association between excess endogenous glucocorticoids
and fractures in 1932. 1 Within a few years after the introduction of prednisone to treat …

Osteoporosis is characterized by reduced bone mass and alteration in bone architecture,
resulting in increased fracture risk. These fractures are a major cause of morbidity and …

Mometasone furoate (MF) and fluticasone propionate (FP) are high potency inhaled
corticosteroids. The systemic bioavailability of MF is claimed to be negligible, leading to a …

Inhaled corticosteroids are widely used in the long-term management of asthma in children.
Data on the relationship between inhaled corticosteroid therapy and osteoporotic fracture …

FRAX is being incorporated in an increasing number of clinical guidelines, and assessment
and intervention thresholds have been provided to instruct clinical decision-making. There is …